Pfizer lays off research scientists in face of Lipitor patent expiry

With Pfizer's Lipitor facing generic competition on or about Nov. 30, 2011, Pfizer announced on 13 Jan 09 the lay-off of up to 800 research scientists and expects to reduce its research staff by 5 percent to 8 percent this year.

See also

http://ipbiz.blogspot.com/2008/06/pfizer-ranbaxy-settle-lipitor-matter.html